Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant RCAS1 antibody

This Mouse Monoclonal antibody specifically detects RCAS1 in IHC. It exhibits reactivity toward Human.
Catalog No. ABIN7863774
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Recombinant RCAS1 antibody (ABIN7863774)

Target

See all RCAS1 (EBAG9) Antibodies
RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

Antibody Type

Recombinant Antibody

Reactivity

  • 67
  • 31
  • 13
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 45
  • 35
  • 2
Mouse

Clonality

  • 43
  • 39
Monoclonal

Conjugate

  • 40
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This RCAS1 antibody is un-conjugated

Application

  • 35
  • 33
  • 20
  • 16
  • 15
  • 13
  • 13
  • 12
  • 5
  • 3
  • 2
  • 2
  • 1
Immunohistochemistry (IHC)

Clone

REBAG9-7264
  • Purpose

    Recombinant RCAS1 / Estrogen Receptor Binding Site Associated, Antigen 9 Antibody

    Specificity

    EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant full-length human EBAG9 protein

    Isotype

    IgG1, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

    Alternative Name

    RCAS1

    Background

    BAG9, cancer associated surface antigen, cancer associated surface antigen RCAS1, EB9, estrogen receptor binding fragment associated gene 9, PDAF, receptor binding cancer antigen expressed on SiSo cells

    Jurkat or HEK-293 cell lysates. Human skeletal muscle tissue.|MCF-7

    Molecular Weight

    32kDa

    Gene ID

    9166, 409368

    UniProt

    O00559
You are here:
Chat with us!